Valeant Pharmaceuticals reported $-315000000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Amgen AMGN:US $ 828M 1301M
Ani Pharmaceuticals ANIP:US $ -15553000 18.6M
Aphria Inc APH:CN C$ -68313000 25.11M
Aurora Cannabis Inc ACB:CN -153455000 1.93M
Biogen BIIB:US $ 794M 308.3M
Bristol Myers Squibb BMY:US $ 1715M 36M
Canopy Growth Corp WEED:CN C$ -190050000 42.52M
Catalent CTLT:US $ 250.5M 100.9M
Corcept Therapeutics CORT:US $ 31.94M 12.3M
Danaher DHR:US $ 2005M 5M
Drreddys Laboratories RDY:US $ 6607M 944M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Endo International Ordinary Shares ENDP:US $ 143.1M 39.58M
Gilead Sciences GILD:US $ 2246M 644M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Horizon Pharma HZNP:US $ 138.51M 298.53M
JAZZ PHA JAZZ:US $ -69.59M 231.71M
Lannett LCI:US $ -33.83M 36.67M
Nektar Therapeutics NKTR:US $ -110.2M 0.81M
Pacira Pharmaceuticals PCRX:US $ 34.84M 15.41M
Perrigo Ordinary Shares PRGO:US $ -125.9M 177.3M
Phibro Animal Health PAHC:US $ 19.16M 0.97M
Prestige Brands PBH:US $ 91.34M 32.73M
Revance Therapeutics RVNC:US $ -70337000 325K
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
Valeant Pharmaceuticals VRX:CN $ -315M 89M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
Zoetis ZTS:US $ 636M 51M